Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 28, 2024 07:30 ET | Source: Optimi Health Corp.

Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference

Optimi Health secures Presenting Sponsorship at the highly anticipated 4th Annual Psychedelic Therapeutics and Drug Development Conference in Boston, MA.
June 29, 2023 08:29 ET | Source: Pasithea

Pasithea Therapeutics Announces Completion of GMP Manufacturing for PAS-004

PALO ALTO, Calif. and MIAMI, June 29, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research,...
February 15, 2023 10:00 ET | Source: TreeFrog Therapeutics

GAIA BioMedicine and TreeFrog Therapeutics Announce Collaboration for the Expansion of Allogeneic NK-like Cells Against Solid Tumors

FUKUOKA, Japan and BORDEAUX, France, Feb. 15, 2023 (GLOBE NEWSWIRE) -- GAIA BioMedicine, a Japan-based clinical-stage company pioneering allogeneic NK-like cell therapies against solid tumors, and...
January 17, 2023 06:00 ET | Source: Forecyte Bio

Forecyte Bio's Grand Opening of the CGMP Facility in Maryland

FREDERICK, Md., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Forecyte Bio, a new global leader in cell and gene therapy contract development and manufacturing, officially opened its 17,000 square feet,...
October 26, 2022 11:57 ET | Source: Panacea Life Sciences Holdings, Inc.

Revolutionary progress made in the inaugural year of the Panacea Cannabinoid Research Center at Colorado State University

GOLDEN, Colo., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Panacea Life Sciences Holdings, Inc. (OTCQB:PLSH) (“Panacea” or the “Company”), a Colorado, USA-based cannabinoid research and certified GMP...
March 01, 2022 09:15 ET | Source: Invectys, Inc.

Invectys appoints Jian Cao, Ph.D., as Vice President, Pharmaceutical Development

Houston, Texas, USA, March 01, 2022 (GLOBE NEWSWIRE) -- Invectys, Inc. of Houston, Texas, a clinical stage immunotherapy company dedicated to the development of a next generation of therapies to...
March 12, 2019 08:05 ET | Source: Aldevron

Aldevron Releases GMP-Grade SpyFi™ Cas9 Nuclease

FARGO, ND, March 12, 2019 (GLOBE NEWSWIRE) -- Aldevron, a leading contract development and manufacturing organization serving the biotech industry, announces the release of GMP SpyFi Cas9 Nuclease...
June 20, 2018 12:03 ET | Source: PCI Synthesis; Novacap

Novacap to expand its pharmaceutical offering in the U.S. with the acquisition of PCI Synthesis

LYON, France and NEWBURYPORT, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has signed an...
December 18, 2017 09:15 ET | Source: PCI Synthesis

PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2018

NEWBURYPORT, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...